Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Jun-10 5:34 PM View:  | Ingram Robert Alexander Director | OSI Pharmaceuticals Inc. (OSIP) | 08-Jun-10 | Disposition | 750 | $57.50 | $43,125.00 | (100%) 0.75K to 0 | < 1% |
| 09-Jun-10 5:36 PM View: | Klein Joseph III Director | OSI Pharmaceuticals Inc. (OSIP) | 08-Jun-10 | Disposition | 8,500 | $57.50 | $488,750.00 | (63%) 13.5K to 5.0K | < 1% |
| 09-Jun-10 5:36 PM View: | Klein Joseph III Director | OSI Pharmaceuticals Inc. (OSIP) | 08-Jun-10 | Disposition | 5,000 | $57.50 | $287,500.00 | (100%) 5.0K to 0 | < 1% |
| 09-Jun-10 5:45 PM View: | Simon Robert L EVP, Pharmaceut. & Tech. Ops | OSI Pharmaceuticals Inc. (OSIP) | 08-Jun-10 | Disposition | 280 | $57.50 | $16,100.00 | (100%) 0.28K to 0 | < 1% |
| 09-Jun-10 5:28 PM View: | Davies Angela M. Sr. VP and CMO, Oncology | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition | 16 | $57.50 | $920.00 | (100%) 16 to 0 | < 1% |
| 09-Jun-10 5:32 PM View: | Goddard Colin Chief Executive Officer Director | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 4,175 | $57.50 | $240,062.00 | (100%) 4.17K to 0 | < 1% |
| 09-Jun-10 5:44 PM View: | Stevenson Katharine Berghuis Director | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 11,490 | $57.50 | $660,675.00 | (100%) 11.49K to 0 | < 1% |
| 09-Jun-10 5:39 PM View: | Lundemose Anker Md, Ph.D, Dsc EVP, Corp. Dev & Strategic Pln | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 1,675 | $57.50 | $96,312.50 | (100%) 1.68K to 0 | < 1% |
| 09-Jun-10 5:41 PM View: | Niemiec David W Director | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 2,125 | $57.50 | $122,188.00 | (100%) 2.13K to 0 | < 1% |
| 09-Jun-10 5:30 PM View: | Epstein David M. Sr. VP and CSO, Oncology | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 8 | $57.50 | $460.00 | (100%) 8 to 0 | < 1% |
| 09-Jun-10 12:42 PM View: | Astellas Pharma Inc. 10% Owner | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Market Purchase | 6,387,300 | $57.50 | $367,268,992.00 | 13% 50.85M to 57.23M | (< 1%) |
| 09-Jun-10 5:51 PM View: | Wood Barbara A Sr. V.P. & General Counsel | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 622 | $57.50 | $35,765.00 | (100%) 0.62K to 0 | < 1% |
| 09-Jun-10 5:25 PM View: | Costa Santo J Director | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 6,500 | $57.50 | $373,750.00 | (100%) 6.5K to 0 | < 1% |
| 09-Jun-10 5:37 PM View: | Leung Gabriel EVP & Pres. Pharma. Business | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 910 | $57.50 | $52,325.00 | (100%) 0.91K to 0 | < 1% |
| 09-Jun-10 5:49 PM View: | White John P Director | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 5,500 | $57.50 | $316,250.00 | (100%) 5.5K to 0 | < 1% |
| 09-Jun-10 5:43 PM View: | Pinedo Herbert Md Phd Director | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 5,342 | $57.50 | $307,165.00 | (100%) 5.34K to 0 | < 1% |
| 09-Jun-10 5:45 PM View: | Simon Robert L EVP, Pharmaceut. & Tech. Ops | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 736 | $57.50 | $42,320.00 | (72%) 1.02K to 0.28K | < 1% |
| 09-Jun-10 5:40 PM View: | Mehta Viren Director | OSI Pharmaceuticals Inc. (OSIP) | 07-Jun-10 | Disposition (change in control) | 375 | $57.50 | $21,562.50 | (100%) 0.38K to 0 | < 1% |
| 08-Jun-10 3:16 PM View: | Astellas Pharma Inc. 10% Owner | OSI Pharmaceuticals Inc. (OSIP) | 04-Jun-10 | Market Purchase | 1,176,030 | $57.50 | $67,621,504.00 | 2% 49.67M to 50.85M | (< 1%) |
| 07-Jun-10 7:50 PM View: | Klein Joseph III Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 5,500 | $57.50 | $316,250.00 | (29%) 19.0K to 13.5K | < 1% |
| 07-Jun-10 8:03 PM View: | Wood Barbara A Sr. V.P. & General Counsel | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 13,500 | $57.50 | $776,250.00 | (49%) 27.37K to 13.87K | < 1% |
| 07-Jun-10 8:16 PM View: | Simon Robert L EVP, Pharmaceut. & Tech. Ops | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Payment of Exercise | 514 | $57.50 | $29,555.00 | (2%) 20.57K to 20.06K | < 1% |
| 07-Jun-10 8:03 PM View: | Wood Barbara A Sr. V.P. & General Counsel | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Payment of Exercise | 628 | $57.50 | $36,110.00 | (5%) 13.87K to 13.24K | < 1% |
| 07-Jun-10 8:03 PM View: | Wood Barbara A Sr. V.P. & General Counsel | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 12,616 | $57.50 | $725,420.00 | (95%) 13.24K to 0.62K | < 1% |
| 07-Jun-10 7:31 PM View: | Goddard Colin Chief Executive Officer Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 67,382 | $57.50 | $3,874,460.00 | (43%) 158.26K to 90.88K | < 1% |
| 07-Jun-10 7:38 PM View: | Costa Santo J Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 7,500 | $57.50 | $431,250.00 | (54%) 14.0K to 6.5K | < 1% |
| 07-Jun-10 7:24 PM View: | Leung Gabriel EVP & Pres. Pharma. Business | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Payment of Exercise | 775 | $57.50 | $44,562.50 | (4%) 21.1K to 20.32K | < 1% |
| 07-Jun-10 7:58 PM View: | Niemiec David W Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 5,500 | $57.50 | $316,250.00 | (23%) 24.0K to 18.5K | < 1% |
| 07-Jun-10 7:24 PM View: | Leung Gabriel EVP & Pres. Pharma. Business | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 19,414 | $57.50 | $1,116,300.00 | (96%) 20.32K to 0.91K | < 1% |
| 07-Jun-10 8:08 PM View: | Rachman Jonathan Sr VP, Diabetes/Obesity R&D | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 12,278 | $57.50 | $705,985.00 | (85%) 14.4K to 2.12K | < 1% |
| 07-Jun-10 7:44 PM View: | Epstein David M. Sr. VP and CSO, Oncology | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 9,809 | $57.50 | $564,018.00 | (73%) 13.35K to 3.54K | < 1% |
| 07-Jun-10 8:16 PM View: | Simon Robert L EVP, Pharmaceut. & Tech. Ops | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 20,105 | $57.50 | $1,156,040.00 | (49%) 40.68K to 20.57K | < 1% |
| 07-Jun-10 7:48 PM View: | White John P Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 12,823 | $57.50 | $737,322.00 | (70%) 18.32K to 5.5K | < 1% |
| 07-Jun-10 8:12 PM View: | Pinedo Herbert Md Phd Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 5,125 | $57.50 | $294,688.00 | (49%) 10.47K to 5.34K | < 1% |
| 07-Jun-10 8:16 PM View: | Simon Robert L EVP, Pharmaceut. & Tech. Ops | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 19,044 | $57.50 | $1,095,030.00 | (95%) 20.06K to 1.02K | < 1% |
| 07-Jun-10 7:40 PM View: | Lundemose Anker Md, Ph.D, Dsc EVP, Corp. Dev & Strategic Pln | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 17,892 | $57.50 | $1,028,790.00 | (58%) 30.62K to 12.73K | < 1% |
| 07-Jun-10 7:22 PM View: | Legault Pierre Exec. VP, CFO & Treasurer | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 1,674 | $57.50 | $96,255.00 | (100%) 1.67K to 0 | < 1% |
| 07-Jun-10 7:28 PM View: | Ingram Robert Alexander Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 18,136 | $57.50 | $1,042,820.00 | (96%) 18.89K to 0.75K | < 1% |
| 07-Jun-10 7:24 PM View: | Leung Gabriel EVP & Pres. Pharma. Business | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 17,225 | $57.50 | $990,438.00 | (45%) 38.32K to 21.1K | < 1% |
| 07-Jun-10 7:54 PM View: | Mehta Viren Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 5,875 | $57.50 | $337,812.00 | (7%) 86.25K to 80.38K | < 1% |
| 07-Jun-10 7:54 PM View: | Mehta Viren Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 80,001 | $57.50 | $4,600,060.00 | (100%) 80.38K to 0.38K | < 1% |
| 07-Jun-10 8:08 PM View: | Rachman Jonathan Sr VP, Diabetes/Obesity R&D | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 2,124 | $57.50 | $122,130.00 | (100%) 2.12K to 0 | < 1% |
| 03-Jun-10 4:51 PM View: | Davies Angela M. Sr. VP and CMO, Oncology | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 4,975 | $57.50 | $286,062.00 | (92%) 5.44K to 0.46K | < 1% |
| 07-Jun-10 7:31 PM View: | Goddard Colin Chief Executive Officer Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 86,708 | $57.50 | $4,985,710.00 | (95%) 90.88K to 4.17K | < 1% |
| 03-Jun-10 4:51 PM View: | Davies Angela M. Sr. VP and CMO, Oncology | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 445 | $57.50 | $25,587.50 | (97%) 0.46K to 16 | < 1% |
| 07-Jun-10 7:28 PM View: | Ingram Robert Alexander Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 11,000 | $57.50 | $632,500.00 | (37%) 29.89K to 18.89K | < 1% |
| 07-Jun-10 7:22 PM View: | Legault Pierre Exec. VP, CFO & Treasurer | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 20,375 | $57.50 | $1,171,560.00 | (92%) 22.05K to 1.67K | < 1% |
| 07-Jun-10 8:00 PM View: | Lee Kenneth B Jr Director | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 11,500 | $57.50 | $661,250.00 | (100%) 11.5K to 0 | < 1% |
| 07-Jun-10 7:40 PM View: | Lundemose Anker Md, Ph.D, Dsc EVP, Corp. Dev & Strategic Pln | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition (change in control) | 11,056 | $57.50 | $635,720.00 | (87%) 12.73K to 1.68K | < 1% |
| 07-Jun-10 7:20 PM View: | Amper Linda E Sr. VP, Human Resources | OSI Pharmaceuticals Inc. (OSIP) | 03-Jun-10 | Disposition | 14,775 | $57.50 | $849,562.00 | (77%) 19.1K to 4.33K | < 1% |
